Literature DB >> 28249972

Debridement and implant retention in the management of hip periprosthetic joint infection: outcomes following guided and rapid treatment at a single centre.

P O Lötscher1, B Kessler1, P Graber1, W Zimmerli1, M Clauss1.   

Abstract

AIMS: To analyse the effectiveness of debridement and implant retention (DAIR) in patients with hip periprosthetic joint infection (PJI) and the relationship to patient characteristics. The outcome was evaluated in hips with confirmed PJI and a follow-up of not less than two years. PATIENTS AND METHODS: Patients in whom DAIR was performed were identified from our hip arthroplasty register (between 2004 and 2013). Adherence to criteria for DAIR was assessed according to a previously published algorithm.
RESULTS: DAIR was performed as part of a curative procedure in 46 hips in 42 patients. The mean age was 73.2 years (44.6 to 87.7), including 20 women and 22 men. In 34 hips in 32 patients (73.9%), PJI was confirmed. In 12 hips, the criteria for PJI were not fulfilled and antibiotics stopped. In 41 (89.1%) of all hips and in 32 (94.1%) of the confirmed PJIs, all criteria for DAIR were fulfilled. In patients with exogenous PJI, DAIR was performed not more than three days after referral. In haematogenous infections, the duration of symptoms did not exceed 21 days. In 28 hips, a single debridement and in six hips two surgical debridements were required. In 28 (87.5%) of 32 patients, the total treatment duration was three months. Failure was noted in three hips (9%). Long-term follow-up results (mean 4.0 years, 1.4 to 10) were available in 30 of 34 (88.2%) confirmed PJIs. The overall successful outcome rate was 91% in 34 hips, and 90% in 30 hips with long-term follow-up results.
CONCLUSION: Prompt surgical treatment with DAIR, following strict diagnostic and therapeutic criteria, in patients with suspected periprosthetic joint infection, can lead to high rates of success in eradicating the infection. Cite this article: Bone Joint J 2017;99-B:330-6. ©2017 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Debridement; Implant retention; Periprosthetic joint infection

Mesh:

Substances:

Year:  2017        PMID: 28249972     DOI: 10.1302/0301-620X.99B3.BJJ-2016-0609.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  20 in total

1.  Outcomes of Debridement, Antibiotics and Implant Retention (DAIR) for Periprosthetic Joint Infection in a High-Volume Arthroplasty Centre.

Authors:  Sriganesh Walkay; David Tran Wallace; Vijay Shankar Coimbatore Balasubramaniam; Rohit Maheshwari; Manish Changulani; Martin Sarungi
Journal:  Indian J Orthop       Date:  2022-05-28       Impact factor: 1.033

2.  Debridement, Antibiotics, and Implant Retention with the Direct Anterior Approach for Acute Periprosthetic Joint Infection Following Primary THA.

Authors:  R L Deijkers; E P M van Elzakker; B G Pijls
Journal:  JB JS Open Access       Date:  2020-05-09

Review 3.  Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 4.  Indications and Guidelines for Debridement and Implant Retention for Periprosthetic Hip and Knee Infection.

Authors:  Douglas A Zaruta; Bowen Qiu; Andrew Y Liu; Benjamin F Ricciardi
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

5.  One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty - a retrospective cohort study.

Authors:  F Ruben H A Nurmohamed; Bruce van Dijk; Ewout S Veltman; Marrit Hoekstra; Rob J Rentenaar; Harrie H Weinans; H Charles Vogely; Bart C H van der Wal
Journal:  J Bone Jt Infect       Date:  2021-01-27

6.  Revision for prosthetic joint infection following hip arthroplasty: Evidence from the National Joint Registry.

Authors:  E Lenguerrand; M R Whitehouse; A D Beswick; S A Jones; M L Porter; A W Blom
Journal:  Bone Joint Res       Date:  2017-06       Impact factor: 5.853

7.  Patient claims in prosthetic hip infections: a comparison of nationwide incidence in Sweden and patient insurance data.

Authors:  Piotr Kasina; Anders Enocson; Viktor Lindgren; Lasse J Lapidus
Journal:  Acta Orthop       Date:  2018-05-29       Impact factor: 3.717

Review 8.  Periprosthetic joint infection: current concepts and outlook.

Authors:  Petra Izakovicova; Olivier Borens; Andrej Trampuz
Journal:  EFORT Open Rev       Date:  2019-07-29

9.  Is cemented revision total hip arthroplasty a reasonable treatment option in an elderly population?

Authors:  Philipp Born; Isabella Manzoni; Thomas Ilchmann; Martin Clauss
Journal:  Orthop Rev (Pavia)       Date:  2019-10-02

10.  Periprosthetic hip infections in a Swedish regional hospital between 2012 and 2018: is there a relationship between Cutibacterium acnes infections and uncemented prostheses?

Authors:  Urban Hedlundh; Michail Zacharatos; Jonas Magnusson; Magnus Gottlander; Johanna Karlsson
Journal:  J Bone Jt Infect       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.